ScreenPoint Medical Expands Breast Cancer Risk Assessment with Biomediq Acquisition ScreenPoint Medical has expanded its breast cancer risk assessment capabilities through the acquisition of Biomediq A/S, enhancing its AI technology for improved detection.

ScreenPoint Medical Expands Breast Cancer Risk Assessment with Biomediq Acquisition #Netherlands #Breast_Cancer #ScreenPoint #Nijmegen #Biomediq